osaterone acetate has been researched along with androstane-3,17-diol in 2 studies
| Studies (osaterone acetate) | Trials (osaterone acetate) | Recent Studies (post-2010) (osaterone acetate) | Studies (androstane-3,17-diol) | Trials (androstane-3,17-diol) | Recent Studies (post-2010) (androstane-3,17-diol) |
|---|---|---|---|---|---|
| 32 | 5 | 3 | 1,124 | 64 | 70 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukabori, Y; Hamataki, N; Honma, S; Kushitani, M; Mieda, M; Takezawa, Y; Yamanaka, H | 1 |
| Honma, S; Inada, R; Makino, M; Mieda, M; Murakoshi, M; Suzuki, M; Yamanaka, H | 1 |
2 other study(ies) available for osaterone acetate and androstane-3,17-diol
| Article | Year |
|---|---|
Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Chlormadinone Acetate; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Male; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Ultrasonography | 1992 |
Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Topics: Administration, Oral; Androgen Antagonists; Androstane-3,17-diol; Animals; Chlormadinone Acetate; Dogs; Estradiol; Male; Microscopy, Electron; Orchiectomy; Organ Size; Prostatic Hyperplasia | 1990 |